Abstract
A new, convenient and high yield route to luzindole, the most commonly used melatonin receptor antagonist, is described. The new method involves the Sonogashira coupling reaction between 2-iodoaniline and 3-phenyl-1-propyne followed by cyclisation of the adduct formed, C-3 indole nitroolefination with 1-(dimethylamino)-2-nitroethylene/TFA, reduction to the respective tryptamine and finally acetylation.
Keywords: Luzindole, melatonin receptor antagonist, ortho-alkynylanilines, nitroolefination, 2-benzyltryptamides
Letters in Organic Chemistry
Title: Melatonin Receptor Antagonist Luzindole: A Facile New Synthesis
Volume: 5 Issue: 6
Author(s): Andrew Tsotinis and Pandelis A. Afroudakis
Affiliation:
Keywords: Luzindole, melatonin receptor antagonist, ortho-alkynylanilines, nitroolefination, 2-benzyltryptamides
Abstract: A new, convenient and high yield route to luzindole, the most commonly used melatonin receptor antagonist, is described. The new method involves the Sonogashira coupling reaction between 2-iodoaniline and 3-phenyl-1-propyne followed by cyclisation of the adduct formed, C-3 indole nitroolefination with 1-(dimethylamino)-2-nitroethylene/TFA, reduction to the respective tryptamine and finally acetylation.
Export Options
About this article
Cite this article as:
Tsotinis Andrew and Afroudakis A. Pandelis, Melatonin Receptor Antagonist Luzindole: A Facile New Synthesis, Letters in Organic Chemistry 2008; 5 (6) . https://dx.doi.org/10.2174/157017808785740561
DOI https://dx.doi.org/10.2174/157017808785740561 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nitric Oxide and Inflammation
Inflammation & Allergy - Drug Targets (Discontinued) Dampening the Progression of Dementia
Current Neurovascular Research Galanin/GALP Receptors and CNS Homeostatic Processes
CNS & Neurological Disorders - Drug Targets Pediatric Cutaneous Graft Versus Host Disease: A Review
Current Pediatric Reviews Therapeutic Potential of Drug Delivery by Means of Lipid Nanoparticles: Reality or İllusion?
Current Pharmaceutical Design Editorial (Thematic Issue: Dopamine in the Brain)
Central Nervous System Agents in Medicinal Chemistry Involvement of the Toxic AGEs (TAGE)-RAGE System in the Pathogenesis of Diabetic Vascular Complications: A Novel Therapeutic Strategy
Current Drug Targets Closure of Patent Foramen Ovale: When and How?
Current Vascular Pharmacology Imaging Amyloid Pathology in the Living Brain
Current Medical Imaging Clinical Utility of Microarrays: Current Status, Existing Challenges and Future Outlook
Current Genomics Development and Tailoring of Hybrid Lipid Nanocarriers
Current Pharmaceutical Design Phage-Displayed Combinatorial Peptide Libraries in Fusion to β-Lactamase as Reporter for an Accelerated Clone Screening: Potential Uses of Selected Enzyme-Linked Affinity Reagents in Downstream Applications
Combinatorial Chemistry & High Throughput Screening Intravenous Immunoglobulin Therapy in Dermatologic Disorders
Inflammation & Allergy - Drug Targets (Discontinued) Trypanothione Reductase: A Target for the Development of Anti- Trypanosoma cruzi Drugs
Mini-Reviews in Medicinal Chemistry Caffeoylquinic Acids with Potential Biological Activity from Plant In vitro Cultures as Alternative Sources of Valuable Natural Products
Current Pharmaceutical Design Progress of HDAC Inhibitor Panobinostat in the Treatment of Cancer
Current Drug Targets A Review on Melatonin’s Effects in Cancer: Potential Mechanisms
Anti-Cancer Agents in Medicinal Chemistry The Possible Involvement of HLA Class III Haplotype (RAGE, HSP70 and TNF Genes) in Alzheimer's Disease
Current Alzheimer Research Preface
Central Nervous System Agents in Medicinal Chemistry Mutational Analysis of the Serotonergic System: Recent Findings Using Knockout Mice
Current Drug Targets - CNS & Neurological Disorders